JP2021531244A - ベータグルカン、グリシチンおよび4’,6,7−トリメトキシイソフラボンを含む創傷治療または皮膚活性用薬学的組成物 - Google Patents

ベータグルカン、グリシチンおよび4’,6,7−トリメトキシイソフラボンを含む創傷治療または皮膚活性用薬学的組成物 Download PDF

Info

Publication number
JP2021531244A
JP2021531244A JP2020571654A JP2020571654A JP2021531244A JP 2021531244 A JP2021531244 A JP 2021531244A JP 2020571654 A JP2020571654 A JP 2020571654A JP 2020571654 A JP2020571654 A JP 2020571654A JP 2021531244 A JP2021531244 A JP 2021531244A
Authority
JP
Japan
Prior art keywords
glycitin
glucan
tmf
beta
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020571654A
Other languages
English (en)
Japanese (ja)
Inventor
ウンジ バク
ジョンデ イ
ソンホン ギム
ビョンヒ バク
ヨンギュン ギム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quegen Biotech Co Ltd
Original Assignee
Quegen Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quegen Biotech Co Ltd filed Critical Quegen Biotech Co Ltd
Publication of JP2021531244A publication Critical patent/JP2021531244A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
JP2020571654A 2018-06-22 2019-06-21 ベータグルカン、グリシチンおよび4’,6,7−トリメトキシイソフラボンを含む創傷治療または皮膚活性用薬学的組成物 Pending JP2021531244A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2018-0072306 2018-06-22
KR1020180072306A KR102321066B1 (ko) 2018-06-22 2018-06-22 베타글루칸, 글리시틴 및 4',6,7-트리메톡시이소플라본을 포함하는 창상 치료 또는 피부 활성용 약학적 조성물
PCT/KR2019/007530 WO2019245332A1 (fr) 2018-06-22 2019-06-21 Composition pharmaceutique pour traiter une plaie ou activer la peau, contenant du bêta-glucane, de la glycitine et de la 4', 6,7-triméthoxyisoflavone

Publications (1)

Publication Number Publication Date
JP2021531244A true JP2021531244A (ja) 2021-11-18

Family

ID=68983322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020571654A Pending JP2021531244A (ja) 2018-06-22 2019-06-21 ベータグルカン、グリシチンおよび4’,6,7−トリメトキシイソフラボンを含む創傷治療または皮膚活性用薬学的組成物

Country Status (5)

Country Link
US (1) US20210260096A1 (fr)
JP (1) JP2021531244A (fr)
KR (1) KR102321066B1 (fr)
CN (1) CN112334142A (fr)
WO (1) WO2019245332A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230041318A (ko) 2021-09-17 2023-03-24 (주) 에빅스젠 세포 투과 펩티드 및 약제를 포함하는 창상 치료용 조성물
CN116549722B (zh) * 2023-06-09 2023-11-10 东莞理工学院 一种细菌纤维素-木葡聚糖-右旋糖酐复合水凝胶伤口敷料及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101547996B1 (ko) * 2014-06-30 2015-08-27 제주대학교 산학협력단 상처 치료, 상처 회복 또는 흉터 생성 억제용 피부 외용제 조성물
JP2016180010A (ja) * 2010-11-29 2016-10-13 ビオテック ファルマコン アルメン アクスイェ セルスカプ グルカン組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1267795A1 (fr) * 2000-03-30 2003-01-02 Brennen Medical Inc. Composition anti-microbienne et immunostimulante
TWI265814B (en) * 2005-09-20 2006-11-11 Taiwan Textile Res Inst Glucan film and applications thereof
KR101109146B1 (ko) * 2009-11-24 2012-02-16 한국원자력연구원 베타글루칸을 함유한 상처치료용 수화겔 및 이의 제조방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016180010A (ja) * 2010-11-29 2016-10-13 ビオテック ファルマコン アルメン アクスイェ セルスカプ グルカン組成物
KR101547996B1 (ko) * 2014-06-30 2015-08-27 제주대학교 산학협력단 상처 치료, 상처 회복 또는 흉터 생성 억제용 피부 외용제 조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PHYTOMEDICINE, vol. 21, JPN6021050215, 2014, pages 570 - 577, ISSN: 0004667602 *

Also Published As

Publication number Publication date
KR102321066B1 (ko) 2021-11-03
KR20200000243A (ko) 2020-01-02
WO2019245332A1 (fr) 2019-12-26
CN112334142A (zh) 2021-02-05
US20210260096A1 (en) 2021-08-26

Similar Documents

Publication Publication Date Title
US5604200A (en) Wound therapeutic mixture containing medical grade hyaluronic acid and tissue culture grade plasma-fibronectin in a delivery system that creates a moist environment which simulates in utero healing
AU2008342920B2 (en) Topical application and formulation of erythropoietin for skin wound healing
CN104352385A (zh) 抗衰老精华液
CN115554187B (zh) 一种可湿热灭菌的贻贝粘蛋白皮肤修护乳液及其制备方法
CN113301910A (zh) 肽组分的皮肤更新和愈合混合物及其用途
WO2017011983A1 (fr) Protéine de moule à action adhésive indiquée pour la protection cutanée et de l'appendice cutané
JP2021531244A (ja) ベータグルカン、グリシチンおよび4’,6,7−トリメトキシイソフラボンを含む創傷治療または皮膚活性用薬学的組成物
RU2470640C1 (ru) Средство для лечения воспалительных заболеваний полости рта и способ лечения воспалительных заболеваний полости рта
KR20210075051A (ko) 하이드로젤 패치를 포함하는 상처 또는 흉터 치료용 조성물
KR20080029364A (ko) 저백피 추출물을 함유하는 화장료 조성물
KR102202391B1 (ko) 상처 치유 및 피부 병변 회복을 위한 알라닌-글루타민, 히알루론산, 귀리 추출물의 상승적 조합 및 조성물로서의 용도
RU2202362C2 (ru) Композиция для местного применения, содержащая фактор роста эпидермиса человека
KR100702329B1 (ko) 백굴채 추출물을 유효성분으로 함유하는 5α-리덕테이즈활성 억제용 조성물 및 피지 분비 억제용 화장료 조성물
KR101917026B1 (ko) 피부 주름 개선 또는 예방용 화장료 조성물
KR20220040464A (ko) 피부 충전제로 병태의 치료를 위한 조성물
JP7361448B2 (ja) トランスグルタミナーゼ発現促進剤
KR101885591B1 (ko) 휴매닌 또는 이의 유사체를 유효성분으로 함유하는 창상 치료용 약학적 조성물
CN113473963A (zh) 化妆品/皮肤病学组合物
KR102672347B1 (ko) 트레할로스를 포함하는 아토피성 피부염 치료용 조성물
CZ20032011A3 (cs) Použití nemetabolizovatelného cukru a polymerového absorpčního činidla pro podporu buněčné rekonstrukce a/nebo buněčné diferenciace
KR20220001141A (ko) 베라파밀을 포함하는 창상 치유용 조성물
RU2142784C1 (ru) Косметическое средство для ухода за кожей "гармония"
JPH07196520A (ja) 変性キトサン組成物
RU2740450C1 (ru) Стоматологический гель с адаптогеном для лечения воспалительных заболеваний пародонта
KR102540969B1 (ko) 소듐 2-메르캅토에탄 설포네이트를 함유하는 피부 재생 촉진용 조성물

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211221

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220712